Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens

Su Young Kim, Sun Hye Shin, Seong Mi Moon, Bumhee Yang, Hojoong Kim, O. Jung Kwon, Hee Jae Huh, Chang Seok Ki, Nam Yong Lee, SungJae Shin, Won Jung Koh

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Mycobacterium avium complex (MAC) was originally composed of 2 species, M. avium and M. intracellulare. However, several new species closely related to M. intracellulare have recently been identified. In addition, M. avium has been further subdivided into 4 subspecies. The aim of this study was to determine the proportion of different MAC species recovered from respiratory specimens and to elucidate the clinical relevance of these species. Clinical isolates, from 219 patients, that had been initially identified as M. avium or M. intracellulare by non-sequencing methods were reidentified using multilocus sequence typing, and the clinical significance of the identified species was then investigated. Of 91 isolates originally identified as M. intracellulare, 75 (82%) were confirmed to be M. intracellulare, 8 (9%) isolates were identified as M. chimaera, and 4 (4%) isolates each were identified as “M. indicus pranii” and M. yongonense. The 128 isolates originally designated as M. avium were determined to be M. avium subsp. hominissuis. Of the 219 patients, 146 (67%) met the diagnostic criteria for MAC lung disease, and for each MAC species, the proportion of patients meeting these criteria was as follows: M. intracellulare (54/75, 72%), M. chimaera (3/8, 38%), “M. indicus pranii” (3/4, 75%), M. yongonense (2/4, 50%), and M. avium subsp. hominissuis (84/128, 66%). In summary, multilocus sequence typing of respiratory isolates initially identified as MAC revealed that, although most isolates were M. avium subsp. hominissuis or M. intracellulare, approximately 7% were newer MAC members, with clinical evidence supporting their potential pathogenicity for humans.

Original languageEnglish
Pages (from-to)125-137
Number of pages13
JournalDiagnostic Microbiology and Infectious Disease
Volume88
Issue number2
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Hospital Distribution Systems
Mycobacterium avium Complex
Mycobacterium avium
Multilocus Sequence Typing
Lung Diseases
Virulence

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Kim, Su Young ; Shin, Sun Hye ; Moon, Seong Mi ; Yang, Bumhee ; Kim, Hojoong ; Kwon, O. Jung ; Huh, Hee Jae ; Ki, Chang Seok ; Lee, Nam Yong ; Shin, SungJae ; Koh, Won Jung. / Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens. In: Diagnostic Microbiology and Infectious Disease. 2017 ; Vol. 88, No. 2. pp. 125-137.
@article{f065fcc403104c778c6ebe053212b85d,
title = "Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens",
abstract = "Mycobacterium avium complex (MAC) was originally composed of 2 species, M. avium and M. intracellulare. However, several new species closely related to M. intracellulare have recently been identified. In addition, M. avium has been further subdivided into 4 subspecies. The aim of this study was to determine the proportion of different MAC species recovered from respiratory specimens and to elucidate the clinical relevance of these species. Clinical isolates, from 219 patients, that had been initially identified as M. avium or M. intracellulare by non-sequencing methods were reidentified using multilocus sequence typing, and the clinical significance of the identified species was then investigated. Of 91 isolates originally identified as M. intracellulare, 75 (82{\%}) were confirmed to be M. intracellulare, 8 (9{\%}) isolates were identified as M. chimaera, and 4 (4{\%}) isolates each were identified as “M. indicus pranii” and M. yongonense. The 128 isolates originally designated as M. avium were determined to be M. avium subsp. hominissuis. Of the 219 patients, 146 (67{\%}) met the diagnostic criteria for MAC lung disease, and for each MAC species, the proportion of patients meeting these criteria was as follows: M. intracellulare (54/75, 72{\%}), M. chimaera (3/8, 38{\%}), “M. indicus pranii” (3/4, 75{\%}), M. yongonense (2/4, 50{\%}), and M. avium subsp. hominissuis (84/128, 66{\%}). In summary, multilocus sequence typing of respiratory isolates initially identified as MAC revealed that, although most isolates were M. avium subsp. hominissuis or M. intracellulare, approximately 7{\%} were newer MAC members, with clinical evidence supporting their potential pathogenicity for humans.",
author = "Kim, {Su Young} and Shin, {Sun Hye} and Moon, {Seong Mi} and Bumhee Yang and Hojoong Kim and Kwon, {O. Jung} and Huh, {Hee Jae} and Ki, {Chang Seok} and Lee, {Nam Yong} and SungJae Shin and Koh, {Won Jung}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.diagmicrobio.2017.02.017",
language = "English",
volume = "88",
pages = "125--137",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "2",

}

Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens. / Kim, Su Young; Shin, Sun Hye; Moon, Seong Mi; Yang, Bumhee; Kim, Hojoong; Kwon, O. Jung; Huh, Hee Jae; Ki, Chang Seok; Lee, Nam Yong; Shin, SungJae; Koh, Won Jung.

In: Diagnostic Microbiology and Infectious Disease, Vol. 88, No. 2, 01.06.2017, p. 125-137.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens

AU - Kim, Su Young

AU - Shin, Sun Hye

AU - Moon, Seong Mi

AU - Yang, Bumhee

AU - Kim, Hojoong

AU - Kwon, O. Jung

AU - Huh, Hee Jae

AU - Ki, Chang Seok

AU - Lee, Nam Yong

AU - Shin, SungJae

AU - Koh, Won Jung

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Mycobacterium avium complex (MAC) was originally composed of 2 species, M. avium and M. intracellulare. However, several new species closely related to M. intracellulare have recently been identified. In addition, M. avium has been further subdivided into 4 subspecies. The aim of this study was to determine the proportion of different MAC species recovered from respiratory specimens and to elucidate the clinical relevance of these species. Clinical isolates, from 219 patients, that had been initially identified as M. avium or M. intracellulare by non-sequencing methods were reidentified using multilocus sequence typing, and the clinical significance of the identified species was then investigated. Of 91 isolates originally identified as M. intracellulare, 75 (82%) were confirmed to be M. intracellulare, 8 (9%) isolates were identified as M. chimaera, and 4 (4%) isolates each were identified as “M. indicus pranii” and M. yongonense. The 128 isolates originally designated as M. avium were determined to be M. avium subsp. hominissuis. Of the 219 patients, 146 (67%) met the diagnostic criteria for MAC lung disease, and for each MAC species, the proportion of patients meeting these criteria was as follows: M. intracellulare (54/75, 72%), M. chimaera (3/8, 38%), “M. indicus pranii” (3/4, 75%), M. yongonense (2/4, 50%), and M. avium subsp. hominissuis (84/128, 66%). In summary, multilocus sequence typing of respiratory isolates initially identified as MAC revealed that, although most isolates were M. avium subsp. hominissuis or M. intracellulare, approximately 7% were newer MAC members, with clinical evidence supporting their potential pathogenicity for humans.

AB - Mycobacterium avium complex (MAC) was originally composed of 2 species, M. avium and M. intracellulare. However, several new species closely related to M. intracellulare have recently been identified. In addition, M. avium has been further subdivided into 4 subspecies. The aim of this study was to determine the proportion of different MAC species recovered from respiratory specimens and to elucidate the clinical relevance of these species. Clinical isolates, from 219 patients, that had been initially identified as M. avium or M. intracellulare by non-sequencing methods were reidentified using multilocus sequence typing, and the clinical significance of the identified species was then investigated. Of 91 isolates originally identified as M. intracellulare, 75 (82%) were confirmed to be M. intracellulare, 8 (9%) isolates were identified as M. chimaera, and 4 (4%) isolates each were identified as “M. indicus pranii” and M. yongonense. The 128 isolates originally designated as M. avium were determined to be M. avium subsp. hominissuis. Of the 219 patients, 146 (67%) met the diagnostic criteria for MAC lung disease, and for each MAC species, the proportion of patients meeting these criteria was as follows: M. intracellulare (54/75, 72%), M. chimaera (3/8, 38%), “M. indicus pranii” (3/4, 75%), M. yongonense (2/4, 50%), and M. avium subsp. hominissuis (84/128, 66%). In summary, multilocus sequence typing of respiratory isolates initially identified as MAC revealed that, although most isolates were M. avium subsp. hominissuis or M. intracellulare, approximately 7% were newer MAC members, with clinical evidence supporting their potential pathogenicity for humans.

UR - http://www.scopus.com/inward/record.url?scp=85014848412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014848412&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2017.02.017

DO - 10.1016/j.diagmicrobio.2017.02.017

M3 - Article

VL - 88

SP - 125

EP - 137

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 2

ER -